Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:617-624

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jager, A.
Right arrow Articles by Stehouwer, C. D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jager, A.
Right arrow Articles by Stehouwer, C. D. A.
Related Collections
Right arrow Risk Factors
Right arrow Peripheral vascular disease
Right arrow Epidemiology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:617-624.)
© 1999 American Heart Association, Inc.


Original Contributions

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

Five-year Follow-up of the Hoorn Study

Agnes Jager; Piet J. Kostense; Henricus G. Ruhé; Robert J. Heine; Giel Nijpels; Jacqueline M. Dekker; Lex M. Bouter; Coen D. A. Stehouwer

From the Institute for Research in Extramural Medicine (A.J., P.J.K., H.G.R., R.J.H., G.N., J.M.D., L.M.B., C.D.A.S.), Department of Epidemiology and Biostatistics (P.J.K., L.M.B.), and Department of Internal Medicine, Academic Hospital (R.J.H., C.D.A.S.), Vrije Universiteit, Amsterdam, The Netherlands.

Correspondence to Dr Coen D.A. Stehouwer, Department of Internal Medicine, Academic Hospital Vrije Universiteit De Boelelaan 1118, 1007 MB Amsterdam, The Netherlands. E-mail cda.stehouwer{at}azvu.nl

Abstract—Microalbuminuria (MA) is associated with increased cardiovascular and all-cause mortality. It has been proposed that MA reflects generalized atherosclerosis and may thus predict mortality. To investigate this hypothesis, we studied the associations between, on the one hand, MA and peripheral arterial disease (PAD), a generally accepted marker of generalized atherosclerosis, and, on the other hand, cardiovascular and all-cause mortality in an age-, sex-, and glucose tolerance-stratified sample (n=631) of a population-based cohort aged 50 to 75 years followed prospectively for 5 years. At baseline, the albumin-to-creatinine ratio (ACR) was measured in an overnight spot urine sample; MA was defined as ACR >2.0 mg/mmol. PAD was defined as an ankle-brachial pressure index below 0.90 and/or a history of a peripheral arterial bypass or amputation. After 5 years of follow-up, 58 subjects had died (24 of cardiovascular causes). Both MA and PAD were associated with a 4-fold increase in cardiovascular mortality. After adjusting for age, sex, diabetes mellitus, hypertension, levels of total and HDL-cholesterol and triglyceride, body mass index, smoking habits, and preexistent ischemic heart disease, the relative risks (RR) (95% confidence intervals) were 3.2 (1.3 to 8.1) for MA and 2.4 (0.9 to 6.1) for PAD. When both MA and PAD were included in the multivariate analysis, the RRs were 2.9 (1.1 to 7.3) for MA and 2.0 (0.7 to 5.7) for PAD. MA and PAD were both associated with an about 2-fold increase in all-cause mortality. The RRs of all-cause mortality associated with MA and PAD were about 4 times higher among hypertensive than among normotensive subjects. We conclude that both MA and PAD are associated with an increased risk of cardiovascular mortality. MA and PAD are mutually independent risk indicators. The associations of MA and PAD with all-cause mortality are somewhat weaker. They are more pronounced in the presence of hypertension than in its absence. These data suggest that MA affects mortality risk through a mechanism different from generalized atherosclerosis.


Key Words: microalbuminuria • peripheral arterial disease • mortality • noninsulin dependent diabetes mellitus • hypertension




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Ann Intern Med, October 6, 2009; 151(7): 496 - 507.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. H. Brantsma, S. J. L. Bakker, H. L. Hillege, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and for the PREVEND Study Group
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. H. Criqui, J. K. Ninomiya, D. L. Wingard, M. Ji, and A. Fronek
Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality
J. Am. Coll. Cardiol., November 18, 2008; 52(21): 1736 - 1742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. He, K. Liu, M. L Daviglus, E. Mayer-Davis, N. S. Jenny, R. Jiang, P. Ouyang, L. M Steffen, D. Siscovick, C. Wu, et al.
Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Ankle Brachial Index Collaboration
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis
JAMA, July 9, 2008; 300(2): 197 - 208.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Rademacher, M. Mauer, D. R. Jacobs Jr, B. Chavers, J. Steinke, and A. Sinaiko
Albumin Excretion Rate in Normal Adolescents: Relation to Insulin Resistance and Cardiovascular Risk Factors and Comparisons to Type 1 Diabetes Mellitus Patients
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. Danziger
Importance of Low-Grade Albuminuria
Mayo Clin. Proc., July 1, 2008; 83(7): 806 - 812.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Basi, P. Fesler, A. Mimran, and J. B. Lewis
Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
Diabetes Care, February 1, 2008; 31(Supplement_2): S194 - S201.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Sheehan, S.-W. Tsaih, B. L. King, C. Stanton, G. A. Churchill, B. Paigen, and K. DiPetrillo
Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1649 - F1656.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Daly
Is early chronic kidney disease an important risk factor for cardiovascular disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix19 - ix25.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]


Home page
CJASNHome page
M. R. Weir
Microalbuminuria and Cardiovascular Disease
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 581 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. M. Mostaza, C. Suarez, L. Manzano, M. Cairols, F. Garcia-Iglesias, J. Sanchez-Alvarez, J. Ampuero, D. Godoy, A. Rodriguez-Samaniego, M. A. Sanchez-Zamorano, et al.
Relationship between Ankle-Brachial Index and Chronic Kidney Disease in Hypertensive Patients with No Known Cardiovascular Disease
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S201 - S205.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Redon, F. Morales-Olivas, A. Galgo, M. A. Brito, J. Mediavilla, R. Marin, P. Rodriguez, S. Tranche, J. V. Lozano, C. Filozof, et al.
Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S236 - S245.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. D.A. Stehouwer and Y. M. Smulders
Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2106 - 2111.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
T. Fukuhara and K. Hida
Pulsatility index at the cervical internal carotid artery as a parameter of microangiopathy in patients with type 2 diabetes.
J. Ultrasound Med., May 1, 2006; 25(5): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. de Jager, J. M. Dekker, A. Kooy, P. J. Kostense, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1086 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Segura, J. A. Garcia-Donaire, M. Praga, and L. M. Ruilope
Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S136 - S140.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Stam, C. van Guldener, A. Becker, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
Endothelial Dysfunction Contributes to Renal Function-Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency: The Hoorn Study
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 537 - 545.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Montalescot and J.-P. Collet
Preserving cardiac function in the hypertensive patient: why renal parameters hold the key
Eur. Heart J., December 2, 2005; 26(24): 2616 - 2622.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
J. Xu, E. T Lee, L. G Best, M. Begum, W. C Knowler, R. R Fabsitz, and B. V Howard
Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study
The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 334 - 340.
[Abstract] [PDF]


Home page
CirculationHome page
J. M. Dekker, C. Girman, T. Rhodes, G. Nijpels, C. D.A. Stehouwer, L. M. Bouter, and R. J. Heine
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Circulation, August 2, 2005; 112(5): 666 - 673.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Redon
Urinary Albumin Excretion: Lowering the Threshold of Risk in Hypertension
Hypertension, July 1, 2005; 46(1): 19 - 20.
[Full Text] [PDF]


Home page
HypertensionHome page
K. P. Klausen, H. Scharling, G. Jensen, and J. S. Jensen
New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death
Hypertension, July 1, 2005; 46(1): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. V. van Hecke, J. M. Dekker, C. D.A. Stehouwer, B. C.P. Polak, J. H. Fuller, A. K. Sjolie, A. Kofinis, R. Rottiers, M. Porta, and N. Chaturvedi
Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence: The EURODIAB Prospective Complications Study
Diabetes Care, June 1, 2005; 28(6): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Pascual, E. Rodilla, C. Gonzalez, S. Perez-Hoyos, and J. Redon
Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension
Hypertension, June 1, 2005; 45(6): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Viazzi, G. Leoncini, D. Parodi, E. Ratto, S. Vettoretti, V. Vaccaro, A. Parodi, V. Falqui, C. Tomolillo, G. Deferrari, et al.
Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S89 - S91.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Furtner, S. Kiechl, A. Mair, K. Seppi, S. Weger, F. Oberhollenzer, W. Poewe, and J. Willeit
Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population
Eur. Heart J., February 1, 2005; 26(3): 279 - 287.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Kramer, R. Toto, R. Peshock, R. Cooper, and R. Victor
Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ibsen, M. H. Olsen, K. Wachtell, K. Borch-Johnsen, L. H. Lindholm, C. E. Mogensen, B. Dahlof, R. B. Devereux, U. de Faire, F. Fyhrquist, et al.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
Hypertension, February 1, 2005; 45(2): 198 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. R. Dyer, P. Greenland, P. Elliott, M. L. Daviglus, G. Claeys, H. Kesteloot, H. Ueshima, J. Stamler, and for the INTERMAP Research Group
Evaluation of Measures of Urinary Albumin Excretion in Epidemiologic Studies
Am. J. Epidemiol., December 1, 2004; 160(11): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. R. Sowers
Treatment of Hypertension in Patients With Diabetes
Arch Intern Med, September 27, 2004; 164(17): 1850 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Korstanje and K. DiPetrillo
Unraveling the genetics of chronic kidney disease using animal models
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F347 - F352.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. R. Dyer, P. Greenland, P. Elliott, M. L. Daviglus, G. Claeys, H. Kesteloot, Q. Chan, H. Ueshima, and J. Stamler
Estimating Laboratory Precision of Urinary Albumin Excretion and Other Urinary Measures in the International Study on Macronutrients and Blood Pressure
Am. J. Epidemiol., August 1, 2004; 160(3): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, G. Jensen, P. Clausen, H. Scharling, M. Appleyard, and J. S. Jensen
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes
Circulation, July 6, 2004; 110(1): 32 - 35.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. S. Jensen, B. Feldt-Rasmussen, K. S. Jensen, P. Clausen, H. Scharling, and B. G. Nordestgaard
Transendothelial lipoprotein exchange and microalbuminuria
Cardiovasc Res, July 1, 2004; 63(1): 149 - 154.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. D. A. Stehouwer
Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 778 - 781.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. F. Yuyun, K.-T. Khaw, R. Luben, A. Welch, S. Bingham, N. E. Day, and N. J. Wareham
A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study
Am. J. Epidemiol., February 1, 2004; 159(3): 284 - 293.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. F Yuyun, K.-T. Khaw, R. Luben, A. Welch, S. Bingham, N. E Day, and N. J Wareham
Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
Int. J. Epidemiol., February 1, 2004; 33(1): 189 - 198.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. Wachtell, H. Ibsen, M. H. Olsen, K. Borch-Johnsen, L. H. Lindholm, C. E. Mogensen, B. Dahlof, R. B. Devereux, G. Beevers, U. de Faire, et al.
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
Ann Intern Med, December 2, 2003; 139(11): 901 - 906.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Romundstad, J. Holmen, H. Hallan, K. Kvenild, and H. Ellekjaer
Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals: Does Sex Matter?: The Nord-Trondelag Health Study (HUNT), Norway
Circulation, December 2, 2003; 108(22): 2783 - 2789.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Hypertension, November 1, 2003; 42(5): 1050 - 1065.
[Full Text] [PDF]


Home page
CirculationHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Circulation, October 28, 2003; 108(17): 2154 - 2169.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. A. Murtaugh, D. R. Jacobs Jr., X. Yu, M. D. Gross, and M. Steffes
Correlates of Urinary Albumin Excretion in Young Adult Blacks and Whites: The Coronary Artery Risk Development in Young Adults Study
Am. J. Epidemiol., October 1, 2003; 158(7): 676 - 686.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. M. Murabito, J. C. Evans, M. G. Larson, K. Nieto, D. Levy, and P. W. F. Wilson
The Ankle-Brachial Index in the Elderly and Risk of Stroke, Coronary Disease, and Death: The Framingham Study
Arch Intern Med, September 8, 2003; 163(16): 1939 - 1942.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Leoncini, F. Viazzi, D. Parodi, S. Vettoretti, E. Ratto, M. Ravera, C. Tomolillo, M. Del Sette, G. P. Bezante, G. Deferrari, et al.
Mild Renal Dysfunction and Subclinical Cardiovascular Damage in Primary Hypertension
Hypertension, July 1, 2003; 42(1): 14 - 18.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
A. T Hirsch and A. M Gotto Jr
Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction
Vascular Medicine, November 1, 2002; 7(4): 323 - 331.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Pontremoli, G. Leoncini, M. Ravera, F. Viazzi, S. Vettoretti, E. Ratto, D. Parodi, C. Tomolillo, and G. Deferrari
Microalbuminuria, Cardiovascular, and Renal Risk in Primary Hypertension
J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S169 - 172.
[Abstract] [Full Text]


Home page
CirculationHome page
H. L. Hillege, V. Fidler, G. F.H. Diercks, W. H. van Gilst, D. de Zeeuw, D. J. van Veldhuisen, R. O.B. Gans, W. M.T. Janssen, D. E. Grobbee, P. E. de Jong, et al.
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population
Circulation, October 1, 2002; 106(14): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. D.A. Stehouwer, M.-A. Gall, J. W.R. Twisk, E. Knudsen, J. J. Emeis, and H.-H. Parving
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death
Diabetes, April 1, 2002; 51(4): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Redon, E. Rovira, A. Miralles, R. Julve, and J. M. Pascual
Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension
Hypertension, March 1, 2002; 39(3): 794 - 798.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease
Vascular Medicine, November 1, 2001; 6(4): 257 - 264.
[Abstract] [PDF]


Home page
Diabetes CareHome page
R. C.P. Go, R. Desmond, J. M. Roseman, D. S.H. Bell, C. Vanichanan, and R. T. Acton
Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes
Diabetes Care, October 1, 2001; 24(10): 1764 - 1769.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. C. Gerstein, J. F. E. Mann, Q. Yi, B. Zinman, S. F. Dinneen, B. Hoogwerf, J. P. Halle, J. Young, A. Rashkow, C. Joyce, et al.
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
JAMA, July 25, 2001; 286(4): 421 - 426.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Roest, J. D. Banga, W. M. T. Janssen, D. E. Grobbee, J. J. Sixma, P. E. de Jong, D. de Zeeuw, and Y. T. van der Schouw
Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women
Circulation, June 26, 2001; 103(25): 3057 - 3061.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer
Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jager, P. J. Kostense, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, A. J. M. Donker, and C. D. A. Stehouwer
Serum Homocysteine Levels Are Associated With the Development of (Micro)albuminuria : The Hoorn Study
Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G.C. Viberti and S.M. Thomas
Searching for new coronary heart disease risk factors
Eur. Heart J., December 1, 2000; 21(23): 1905 - 1906.
[PDF]


Home page
LupusHome page
P R J Ames, C Tommasino, J Alves, J D Morrow, L Iannaccone, G Fossati, S Caruso, F Caccavo, and V Brancaccio
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study
Lupus, November 1, 2000; 9(9): 688 - 695.
[Abstract] [PDF]


Home page
HypertensionHome page
J. S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johnsen
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Hypertension, April 1, 2000; 35(4): 898 - 903.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Pedrinelli, G. Dell'Omo, G. Penno, S. Bandinelli, A. Bertini, V. Di Bello, and M. Mariani
Microalbuminuria and Pulse Pressure in Hypertensive and Atherosclerotic Men
Hypertension, January 1, 2000; 35(1): 48 - 54.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Kario, S. Hoshide, K. Shimada, T. G. Pickering, R. S. Khattar, R. Senior, and A. Lahiri
White-Coat Hypertension Versus Sustained Hypertension in Japan • Response • Response
Circulation, December 21, 1999; 100 (25): e157 - e158.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, J. S. Yudkin, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study
Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 3071 - 3078.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598.
[Abstract] [Full Text] [PDF]